BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. May 16, 2026; 18(5): 119587
Published online May 16, 2026. doi: 10.4253/wjge.v18.i5.119587
Table 2 Post-living donor liver transplant anastomotic biliary stricture management outcomes
Stricture status
Total, n (%)
No. of ERCP (mean ± SD)
Duration between liver transplant to 1st ERCP (months)
Anastomosis, n (%)
Single
2 ducts
2 ducts on a single patch
Patients completing the therapeutic course1145.18 ± 2.015.89 ± 5.58 (95%CI: 4.87-6.91)67 (58.8)36 (31.6)11 (9.6)
Stricture resolution with endo therapy alone102 (90.2)5.04 ± 2.046 ± 5.77 (95%CI: 4.88-7.12)58 (86.6)33 (91.7)11 (100)
Percutaneous transhepatic cholangioscopy referrals (cannulation failure/inability to traverse the stricture via ERCP)11 (9.7)6.27 ± 1.355.10 ± 3.65 (95%CI: 2.94-7.26)8 (13.4)3 (9.3)-
Redo surgery1 (0.9)7.03.271 (100)--
Combined percutaneous transhepatic cholangioscopy & endotherapy success rates113 (99.1)5.16 ± 2.025.92 ± 5.59 (95%CI: 4.89-6.95)66 (98.5)36 (100)11 (100)
Stricture recurrence rates15 (13.27)7.5 ± 1.95.93 ± 4.57 (95%CI: 3.62-8.24)6 (9.1)7 (19.4)2 (18.2)


Write to the Help Desk